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How to Interpret a Functional or Motility Test 
- Sphincter of Oddi Manometry
Young Koog Cheon
Digestive Disease Center, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea
To date, endoscopic manometry is the best method for evaluating the function of the sphincter. Sphincter of Oddi manometry 
(SOM) remains the gold standard to correctly diagnose the sphincter of Oddi dysfunction (SOD) and stratify therapy. Several 
dynamic abnormalities relating to the intensity, frequency, and propagation of sphincter contractions have been described. 
However, their clinical use generally has been abandoned in favor of basal sphincter pressure alone, because this measurement 
is stable over time, and has stronger interobserver reliablility, reproducibility on repeating testing, and is associated with the 
responsiveness to therapy. A significant elevated risk of pancreatitis was attributed to the technique. The risk of pancreatitits 
associated with manometric evaluation of the pancreatic sphincter is markedly reduced when manometry is performed with 
continous aspiration from the pancreatic duct via one of the 3 catheter lumens. This section reviews indications, conscious 
sedative drugs, techniques, and the appropriate interpretations of SOM.
(J Neurogastroenterol Motil 2012;18:211-217)
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Introduction
Sphincter of Oddi dysfunction (SOD) refers to an abnormal-
ity of sphincter of Oddi (SO) contractility. It is a benign, non-
calculous obstruction to flow of bile or pancreatic juice through 
the pancreatobiliary junction, ie, the SO that causes pain and may 
or may not be associated with pancreatitis, abnormal liver tests, 
and dilated ducts.
1,2 Two types of SOD have been proposed on 
the basis of pathogenic mechanisms: stenosis and dyskinesia.
3,4 
SO stenosis is a structural abnormality in which there is narrow-
ing in part or all of the sphincter because of chronic inflammation 
and fibrosis. It is associated with pancreatitis or injury from gall-
stone migration through the papilla, trauma from intraoperative 
manipulation of the common bile duct, or nonspecific inflam-
matory conditions. SO dyskinesia refers to a primary motor ab-
normality of the SO which may result in a hypertonic sphincter. 
Because it is often impossible to distinguish patients with SO dys-
kinesia from those with SO stenosis, the term SOD has been used 
to incorporate both groups of patients. In an attempt to deal with 
this overlap in etiology, and also to determine the appropriate uti-
lization of SO manometry (SOM), a clinical classification system 
has been developed for patients with suspected SOD (Table 1).
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Table 1. Hogan-Geenen Sphincter of Oddi Classification System Related to the Frequency of Abnormal Sphincter of Oddi Manometry and 





Probability of pain relief by 




  Biliary-type pain
  Abnormal AST or ALP  > ×2 normal
  Delayed drainage of ERCP contrast from the biliary tree > 45 min
  Dilated CBD > 12 mm diamter
75-95 90-95 90-95 Unnecessary
Biliary II (%)
  Biliary-type pain
  Only 1 or 2 of the above criteria
55-65 85 35 Highly 
recommended
Biliary III (%)
  Only biliary-type pain
25-60 55-65 < 10 Mandatory
AST, aspartate aminotransferase; ALP, alkaline phosphatase; ERCP, endoscopic retrograde cholangiopancreatography; CBD, common bile duct.
Sphincter of Oddi Manometry
SOM is the only available method to measure SO motor ac-
tivity directly. Additionally, it is the only modality for diagnosis of 
suspected SOD which has been demonstrated to be reproducible 
and predictive of positive therapeutic outcome results. SOM is 
usually performed at the time of endoscopic retrograde chol-
angiopancreatography (ERCP).
Indications
SOM is recommended in patients with idiopathic pan-
creatitis or unexplained disabling pancreaticobiliary pain with or 
without hepatic enzyme abnormalities. The Rome III committee
6 
concluded that biliary (and pancreatic) pain classically occurs in 
recurrent episodes of steady, severe, pain located in the epigas-
trium and/or the right upper abdominal quadrant lasting ≥ 30 
minutes, and not relieved by bowel movements, postural changes, 
or antacids. In the abscence structural diseases (eg, gallstones, 
pancreatitis or malignancy), such pains may be the clinical pre-
sentation which have originated from gallbladder or SOD.
Indications for the use of SOM have also been developed ac-
cording to the Hogan-Geenen SOD classification system (Table 
1). In Type I patients, there is a general consensus that a struc-
tural disorder of the sphincter (ie, sphincter stenosis) exists. 
Although SOM may be useful in documenting SOD, it is not an 
essential diagnostic study prior to endoscopic or surgical sphincter 
ablation. Such patients uniformly benefit from sphincterotomy 
regardless of the SOM results. Type II patients demonstrate SO 
motor dysfunction in 50% to 65% of cases. In this group of pa-
tients, SOM is highly recommended as the results of the study 
predict outcome from sphincterotomy. Type III patients have 
pancreaticobiliary pain without other objective evidence of 
sphincter outflow obstruction. SOM is mandatory to confirm the 
presence of SOD. Although not well studied, it appears that the 
results of SOM may predict outcome from sphincter ablation in 
these patients. 
Many endoscopists assumed that post-ERCP pancreatitis af-
ter SOM was related to pancreatic duct manipulation. They 
therefore first obtained selective cannulation of the biliary tree 
and then performed SOM, assuring avoidance of pancreatic duct 
manometry. However, there is no evidence suggesting that this 
approach reduces the risk of pancreatitis, but a reasonable 
amount of data now suggests that some patients have isolated 
sphincter abnormalities, and mandates both ducts to be studied 
for complete evaluation of the SO.
7,8 In a series of 360 patients 
with pancreatobiliary pain, 19% had abnormal pancreatic sphinc-
ter pressure alone, 11% had abnormal biliary basal sphincter 
pressure alone and in 31% both the biliary and pancreatic pres-
sures were elevated.
8 Hence, both the bile duct and pancreatic 
duct must be evaluated to obtain complete assessment of the SO.
Methods
Premedications and Sedations
Performance of SOM requires significant experience on Sphincter of Oddi Manometry
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Figure 1. Sphincter of Oddi catheter. Triple-lumen catheter with a long
intraductal tip helps secure the catheter within the bile duct.
Figure 2. Aspirating sphincter of Oddi manometry catheter. A modi-
fied catheter that allows continuous decompression by gentle syrige 
aspiration through an end hole and side hole, while recording pressures 
from 2 other ports.
both ERCP and manometric testing. All drugs which relax 
(anticholinergics, nitrates, calcium channel blockers and gluca-
gon) or stimulate (narcotics or cholinergic agents) the sphincter 
should be avoided for at least 8-12 hours prior to manometry and 
during the manometric session.
1 Recently, I found that phospho-
diesterase type 5 inhibitors (eg, sildenafil, vardenafil and tadala-
fil), which have been used to treat erectile dysfunction, inhibits 
SO motility in patients with suspected SOD.
9 Diazepam 
(benzodiazepines), long the sole standard agent used for per-
formance of SOM, has no significant effect on normal SO mo-
tility,
10,11 but its effect on hypertensive sphincters is unknown. 
Previously published controlled trials of midazolam compared 
with saline solution injection during sedation with diazepam 
demonstrate significant reductions in both normal and elevated 
basal pressures and in peak phasic pressures but not in phasic 
wave amplitude, frequency or propagation.
12 Based on these re-
sults, investigators have advised that midazolam should not be 
used for sedation during SOM. Only limited studies are reported 
on the effect of propofol on sphincter pressures. A study that used 
a canine model demonstrated no significant effect when small bo-
lus doses (< 5 mg/kg) were administered, but elevations in both 
duodenal activity and SO basal and phasic pressures and con-
traction frequencies were observed with higher doses.
13 Meperi-
dine, at a dose of ≤ 1 mg/kg, does not affect the basal sphincter 
pressure.
14 It was suggested that meperidine could be used to fa-
cilitate conscious sedation for manometry.
Sphincter of Manometry Technique
Manometry catheters and manometor
There are currently 3 types of manometric pressure record-
ing catheters used in SOM studies. Five-French catheters 
should be used, since virtually all standards have been established 
with these catheters. Triple-lumen (1.7 mm) catheters are state of 
the art and are available from several manufacturers. Catheters 
with a long intraductal tip may help secure the catheter within the 
bile duct, but such a long nose is commonly a hindrance if pan-
creatic manometry is desired. Some triple-lumen catheters will 
accomodate a 0.018 inch diameter guidewire through the entire 
length of the catheter and can be used to facilitate cannulation or 
maintain position in the duct (Lehman sphincter manometry 
catheter; Cook Endoscopy, Winston-Salem, NC, USA) (Fig. 1). 
Pancreatitis, a potentially serious consequence of this procedure, 
has been reported. A modified triple lumen 5 Fr SOM catheter 
(aspiration catheter) has been developed in an attempt to reduce 
the risk of pancreatitis.
15 A modified catheter allowed continuous 
decompression by gentle syringe aspiration (using a 3 or 5 mL 
syringe) through an end hole and side hole, while recording pres-
sures from the 2 other ports (Fig. 2).
The perfused systems utilize the Arndorfer pneumocapillary 
hydraulic pump; fluid is infused at the rate of 0.25 mililiters per 
minute during SO recording. The perfusate is generally distilled 
water, although physiologic saline needs further evaluation. The 
latter may crystallize in the capillary tubing of perfusion pumps 
and must be flushed out frequently.
1
SOM requires selective cannulation of the bile duct and/or 
pancreatic duct (Fig. 3A). The duct entered can be identified by 
gently aspirating on any port. The appearance of yellow-colored 
fluid in the endoscopic view indicated entry into the bile duct 
(Fig. 3B). Clear aspirate indicates the entrance to the pancreatic 
duct. Some investigators prefer to obtain a cholangiogram and/or 
pancreatogram prior to performing SOM as certain findings may Young Koog Cheon
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Table 2.Suggested Standard for Abnormal Values for Endoscopic 
SOM Obtained From 50 Volunteers Without Abnor-
mal Symptoms
a (Adapted from Guelrud et al
16)
Basal sphincter pressure
b > 35 mmHg
Basal ductal pressure > 13 mmHg
Phasic contractions
   Amplitude
   Duration




aValues were obtained by adding 3 deviations to the mean (means were obtained
by averaging the results on 2 or 3 station pull-throughs). Data combine 
pancreatic and biliary studies. 
bBasal pressures determined by (1) reading the 
peak basal pressure (ie, the highest single lead as obtained using a 3 lumen 
catheter) and (2) obtaining the mean of these peak pressures from multiple 
station pull-throughs.
Figure 3. Sphincter of manometry technique. (A) Endoscopic retrograde 
cholangiopancreatography shows a 0.018 inch diameter guidewire inser-
ted into the common bile duct without injection contrast. (B) The 
endoscopy shows the appearance of yellow-colored fluid in the aspirating 
manometric catheter which indicates entry into the bile duct. (C) The 
endoscopy show a manometric catheter passed through the papilla. (D) 
Abnormal sphincter of Oddi (SO) pressure profile. Elevated basal SO 
pressure is recorded during manometric catheter pull-through of the 
biliary segment of the SO. 
obviate the need for SOM. However, I do not recommend the 
contrast injection into the bile duct and/or pancreatic duct prior 
to performing SOM since contrast injection may affect SO mo-
tility and develop pancreatitis. Once deep cannulation is achieved 
and the catheter is withdrawn across the sphincter at 1-2 mm in-
tervals by standard station pull-through technique until a phasic 
high-pressure zone is located, then the high pressure zone is re-
corded, pausing 30 to 60 seconds at each station where the max-
imum activity is present (Fig. 3C-D). During pressure record-
ings, catheter position is continuously monitored endoscopically 
by observing the position of the catheter marks relative to the 
papillary orifice.
Normal Values for Sphincter of Manometry
The best study establishing normal values for SOM was re-
ported by Guelrud et al.
16 Fifty asymptomatic control subjects 
were evaluated, and the normal values for intraductal pressure, 
basal sphincter pressure, and phasic wave parameters were estab-
lished (Table 2). Also, the reproducibility of SOM was confir-
med. Sphincter of Oddi Manometry
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Figure 4. Schematic representation of a sphincter of Oddi manometry 
recording. Note that the basal sphincter pressure is the baseline pressure 
between phasic waves (using the duodenal pressure as the zero reference
point). Adapted from Sherman et al.
15 CBD, common bile duct; SO, 
sphincter of Oddi.
Interpretation of a Sphincter of Tracing
After each ductal and pull-through recording, duodenal 
pressure is measured as the zero reference. Alternatively, intra-
duodenal pressure can be continuously recorded from a separate 
intraduodenal catheter attached to the endoscope. However, the 
latter is a cumbersome process. First, identify the highest basal 
pressure (Fig. 4) that is sustained for at least 30 seconds (and 
preferably over 1 minute).
1 Then take the 4 lowest amplitude 
points in that zone and take the mean of these readings as the bas-
al sphincter pressure for the highest basal pressure lead for a cath-
eter pull-through. Average the basal sphincter pressure for all in-
terpretable observations and take this as the final basal sphincter 
pressure. The ampiltude of phasic wave contractions is measured 
from the beginning of slope of the pressure increase from basal 
pressure to peak of the contraction wave. Four representative 
waves are taken from each lead and the mean pressure is deter-
mined. The number of phasic waves per minute and the duration 
can also be determined. The most important SO manometric fea-
ture is the basal SO pressure. Most authorities agree that a basal 
SO pressure measurement equal to or greater than 40 mmHg is 
an abnormal value. It should be emphasized that the only study 
evaluating “normal healthy subjects” determined an abnormal 
basal SO pressure as ≥ 35 mmHg.
16 Normal pressure within the 
pancreatic duct is slightly higher than in the bile duct. Normal 
pancreatic sphincter pressures are accepted as the same as for the 
bile duct, however, control data are limited.
Cautions in the Interpretation of Sphincter 
of Manometry
There are several important mechanical factors that are ac-
knowledged as having an effect on SO pressures; (1) tip im-
paction of the manometry catheter against the ductal wall 
(applying excess force onto the catheter with the endoscope’s ele-
vator) and air bubbles within the perfusion system; (2) specific 
medications are unlikely, but may affect SOM (diazepam, dro-
peridol and meperidine have a token effect on sphincter activity 
but do not change biliary basal sphincter pressure);
17,18 and (3) 
contrast injection into the common bile duct may also affect SO 
motility. As a rule, it appears that cholangiography generates 
pressure modifications within the biliary system, although these 
changes are likely to be predictably small and probably clinically 
insignificant.
19
During fasting, the motility of the intestine in most non-
ruminant animals exhibits a cyclic change called the migrating 
motor complex.
20 Carlson et al
21 divided each cycle of this varia-
tion into 4 phases. Phase I is characterized by the relative absence 
of contraction. Phase II consists of pregressively increasing, in-
termittent contractile activity. Phase II culminates abruptly in 
phase III, which is characterized by regular, high-amplitude 
contractions. Phase IV is a short transitional period back to an-
other period of quiescence in phase I. The period of a complete 
cycle is around 100 minutes in humans.
22 In duodenal phase I, 
the SO shows irregular myoelectric activity and irregular con-
tractions by manometry even when the duodenum is quiescent. 
SO basal pressure and common bile duct pressure is high during 
this phase.
23 In duodenal phase II, the SO shows increasing myo-
electric activity and more powerful and frequent contractions by 
manometry. In duodenal phase III, the SO exhibits regular 
strong myoelectric and contractile activity. The SO contractions 
are most powerful and frequent during this phase. Because of the 
similarity of motility in the duodenum and SO during phase III, 
some authors have considered that the SO did not have in-
dependent motility.
24 However, the fact that the SO continues to 
contract during the quiescence of duodenal phase I supports the 
independent nature of SO motility.
25
Limitations
The limitations of SOM performed during ERCP are those 
posed by altered upper gastrointestinal tract anatomy. Although Young Koog Cheon
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SOM can be performed intraoperatively and percutaneously, it is 
most commonly done in the ERCP setting. Experienced endo-
scopic skills are required to cannulate the appropriate ductal sys-
tem and to perform SOM carefully. It is essential that the endo-
scopist has the appropriate patience and interest to adequately 
complete the study.
Complications
SOM is combined with a diagnostic ERCP examination. 
This complexity of procedures often compounds the complica-
tion rate. Most common major complication after SOM is acute 
pancreatitis. Using standard perfused catheters, pancreatitis rates 
as high as 31% have been reported.
26 On rare occations, the pan-
creatitis may be very severe and life threatening. The morbidity 
associated with this study increases if the pancreatic duct is can-
nulated and pressures are recorded from the pancreatic duct seg-
ment of the SO. The incidence of pancreatitis has been shown to 
be reduced with lower rates of manometric catheter perfusion
27 or 
by use of one of the manometric catheter as an aspirating port 
rather than as a measurement channel.
15 This latter approach de-
creases the incidence of post-ERCP pancreatitis following pan-
creatic duct manometry. Recently, microtransducer manometry 
system has been developed.
28 The electronic microtransducer 
manometry system assembly consistes of a 4-Fr catheter, sol-
id-state catheter (SSC), with an atraumatic metal tip (UniTip 
gastrointestinal pressure sensor catheter, Unisensor; Standard 
Instruments, Karlsruhe, Germany). The catheter is connected to 
a small portable instrument, which features a display to allow re-
al-time observation of the pressure recording during endoscopy. 
SOM with SSC may lead to a decreased risk of post-ERCP pan-




Despite the recent dramatic advances in the understanding of 
SO function, many unresolved physiological and clincal issues 
remain. SOM has aided the understanding of the pressure dy-
namics of the SO. The creation of the hydraulic-capillary man-
ometry system, a low compliance system highly sensitive to sud-
den pressure changes, permitted accurate manometry of the SO. 
SOM has become a useful diagnostic tool in evaluating patients 
with unexplained pancreatico-biliary pain or idiopathic pancreati-
tis. SOM is highly recommended for type II patients and is man-
datory for all type III patients if sphincter ablation is contem-
plated. Other causes of abdominal pain such as chronic pan-
creatitis or functional disordrs should be considered in patients 
not benefiting from sphincter ablation. SOM requires endo-
scopist’s experience and is a invasive procedure. For now, SOM 
in the evaluation of chronic abdominal pain should be limited to 
patients with evidence suggestive of SOD.
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